Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARHGEF26 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:36331819 | (S)-nicotine | multiple interactions | EXP | | 6480464 | [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of ARHGEF26 mRNA | CTD | PMID:28065790 | 1,2-dimethylhydrazine | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ARHGEF26 mRNA | CTD | PMID:19619570 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ARHGEF26 mRNA | CTD | PMID:31614463 | 17beta-estradiol | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ARHGEF26 mRNA | CTD | PMID:32145629 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ARHGEF26 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ARHGEF26 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGEF26 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases phosphorylation | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased phosphorylation of ARHGEF26 protein | CTD | PMID:23298284 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARHGEF26 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGEF26 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGEF26 mRNA | CTD | PMID:19619570 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:26705709 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of ARHGEF26 mRNA | CTD | PMID:25172293 | 4,4'-sulfonyldiphenol | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ARHGEF26 mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ARHGEF26 mRNA | CTD | PMID:28973697 | 5-bromo-2'-deoxyuridine | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [Bromodeoxyuridine co-treated with furan] affects the expression of ARHGEF26 mRNA | CTD | PMID:24910943 | 6-propyl-2-thiouracil | increases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ARHGEF26 mRNA | CTD | PMID:22504374 | 6-propyl-2-thiouracil | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ARHGEF26 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of ARHGEF26 mRNA | CTD | PMID:28959563 | amphotericin B | increases expression | EXP | | 6480464 | Amphotericin B results in increased expression of ARHGEF26 mRNA | CTD | PMID:20849824 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ARHGEF26 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ARHGEF26 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ARHGEF26 5' UTR and Benzo(a)pyrene results in increased methylation of ARHGEF26 exon | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ARHGEF26 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ARHGEF26 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ARHGEF26 mRNA | CTD | PMID:32528016 and PMID:34947998 | bisphenol A | affects expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ARHGEF26 mRNA | CTD | PMID:30816183 | bisphenol F | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ARHGEF26 mRNA | CTD | PMID:30951980 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ARHGEF26 mRNA | CTD | PMID:26079696 | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of ARHGEF26 protein | CTD | PMID:35688186 | carbon nanotube | affects expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of ARHGEF26 mRNA | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of ARHGEF26 mRNA | CTD | PMID:25620056 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ARHGEF26 gene] | CTD | PMID:28238834 | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of ARHGEF26 mRNA | CTD | PMID:30690063 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ARHGEF26 mRNA | CTD | PMID:20849824 and PMID:27392435 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ARHGEF26 mRNA | CTD | PMID:27392435 | clobetasol | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of ARHGEF26 mRNA | CTD | PMID:27462272 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ARHGEF26 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ARHGEF26 mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ARHGEF26 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA | CTD | PMID:19167446 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of ARHGEF26 mRNA | CTD | PMID:19167446 | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of ARHGEF26 mRNA | CTD | PMID:20849824 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ARHGEF26 mRNA | CTD | PMID:25562108 | dibenz[a,h]anthracene | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | diuron | increases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Diuron results in increased expression of ARHGEF26 mRNA | CTD | PMID:25152437 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ARHGEF26 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA | CTD | PMID:19167446 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of ARHGEF26 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ARHGEF26 mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Ethanol results in increased expression of ARHGEF26 mRNA | CTD | PMID:30319688 | ethanol | affects splicing | ISO | Arhgef26 (Mus musculus) | 6480464 | Ethanol affects the splicing of ARHGEF26 mRNA | CTD | PMID:30319688 | flutamide | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of ARHGEF26 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ARHGEF26 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of ARHGEF26 mRNA | CTD | PMID:27664576 | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of ARHGEF26 protein | CTD | PMID:37730182 | fulvestrant | increases methylation | EXP | | 6480464 | Fulvestrant results in increased methylation of ARHGEF26 gene | CTD | PMID:31601247 | furan | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [Bromodeoxyuridine co-treated with furan] affects the expression of ARHGEF26 mRNA | CTD | PMID:24910943 | genistein | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Genistein results in increased expression of ARHGEF26 mRNA | CTD | PMID:32186404 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ARHGEF26 mRNA | CTD | PMID:20849824 | gentamycin | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ARHGEF26 mRNA | CTD | PMID:33387578 | glycerol | multiple interactions | EXP | | 6480464 | [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of ARHGEF26 mRNA | CTD | PMID:28065790 | hydroquinone | decreases expression | EXP | | 6480464 | hydroquinone results in decreased expression of ARHGEF26 mRNA | CTD | PMID:31256213 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ARHGEF26 protein | CTD | PMID:32959892 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGEF26 mRNA | CTD | PMID:35811015 | methimazole | increases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of ARHGEF26 mRNA | CTD | PMID:22504374 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ARHGEF26 mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ARHGEF26 mRNA | CTD | PMID:24810058 | nicotine | multiple interactions | EXP | | 6480464 | [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of ARHGEF26 mRNA | CTD | PMID:28065790 | paraquat | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of ARHGEF26 mRNA | CTD | PMID:32680482 | perfluorohexanesulfonic acid | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ARHGEF26 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ARHGEF26 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | Arhgef26 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGEF26 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ARHGEF26 mRNA | CTD | PMID:20813756 and PMID:23811191 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of ARHGEF26 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of ARHGEF26 mRNA | CTD | PMID:22714537 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of ARHGEF26 mRNA | CTD | PMID:28903501 | propane-1,2-diol | multiple interactions | EXP | | 6480464 | [Nicotine co-treated with Propylene Glycol co-treated with Glycerol co-treated with Flavoring Agents] results in increased expression of ARHGEF26 mRNA | CTD | PMID:28065790 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGEF26 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF26 mRNA | CTD | PMID:27188386 | sodium arsenate | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of ARHGEF26 mRNA | CTD | PMID:30953684 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ARHGEF26 mRNA | CTD | PMID:34032870 | sulforaphane | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | sulforaphane results in decreased expression of ARHGEF26 mRNA | CTD | PMID:30529165 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of ARHGEF26 mRNA | CTD | PMID:31533062 | tetrachloroethene | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of ARHGEF26 mRNA | CTD | PMID:28973375 | tetrachloromethane | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of ARHGEF26 mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ARHGEF26 mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARHGEF26 mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ARHGEF26 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ARHGEF26 mRNA | CTD | PMID:23557971 | trichloroethene | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of ARHGEF26 mRNA | CTD | PMID:28973375 | trimellitic anhydride | decreases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of ARHGEF26 mRNA | CTD | PMID:19042947 | triphenyl phosphate | affects expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | triphenyl phosphate affects the expression of ARHGEF26 mRNA | CTD | PMID:30589522 | triptonide | increases expression | ISO | Arhgef26 (Mus musculus) | 6480464 | triptonide results in increased expression of ARHGEF26 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of ARHGEF26 mRNA | CTD | PMID:29024780 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ARHGEF26 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ARHGEF26 mRNA | CTD | PMID:28001369 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ARHGEF26 mRNA | CTD | PMID:23179753 and PMID:27188386 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of ARHGEF26 gene | CTD | PMID:29154799 | vinclozolin | affects expression | ISO | Arhgef26 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of ARHGEF26 mRNA | CTD | PMID:19015723 | |